CONSULTING AGREEMENTConsulting Agreement • December 21st, 2022 • Oncocyte Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledDecember 21st, 2022 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (this “Agreement”), dated as of December 16, 2022 is hereby entered into by and between OncoCyte Corporation (the “Company”) and Douglas Ross (the “Consultant” and, collectively with the Company, the “Parties”).
CONSULTING AGREEMENTConsulting Agreement • December 5th, 2022 • Oncocyte Corp • In vitro & in vivo diagnostic substances • Tennessee
Contract Type FiledDecember 5th, 2022 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (this “Agreement”), dated as of December 1, 2022 is hereby entered into by and between OncoCyte Corporation (the “Company”) and Ronald A. Andrews (the “Consultant” and, collectively with the Company, the “Parties”).